Does DARATUMUMAB Cause Ocular hyperaemia? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Ocular hyperaemia have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.2% of all adverse event reports for DARATUMUMAB.
42
Reports of Ocular hyperaemia with DARATUMUMAB
0.2%
of all DARATUMUMAB reports
12
Deaths
11
Hospitalizations
How Dangerous Is Ocular hyperaemia From DARATUMUMAB?
Of the 42 reports, 12 (28.6%) resulted in death, 11 (26.2%) required hospitalization, and 13 (31.0%) were considered life-threatening.
Is Ocular hyperaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Ocular hyperaemia?
DUPILUMAB (6,938)
CYCLOSPORINE (1,508)
BIMATOPROST (1,447)
CENEGERMIN-BKBJ (1,226)
BRIMONIDINE (917)
ADALIMUMAB (714)
LATANOPROST (587)
DORZOLAMIDE\TIMOLOL (581)
LIFITEGRAST (570)
TRAVOPROST (478)
Which DARATUMUMAB Alternatives Have Lower Ocular hyperaemia Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE